The obstructive sleep apnea (OSA) therapeutic landscape is rapidly expanding with 18+ companies developing 22+ pipeline drugs across multiple mechanisms of action. Eli Lilly's ZEPBOUND (tirzepatide) became the first FDA-approved pharmacological treatment for OSA in December 2024. Other major players including Apnimed, Amgen, Mosanna Therapeutics, and Incannex Healthcare are advancing late-stage candidates targeting weight loss, neuromuscular function, and airway control through diverse delivery methods.
SAP is consolidating approximately 1,000 employees from its Plano and Allen offices to a new regional headquarters in Addison's Spectrum Center, set to open mid-2027. The facility will house business operations, software development, and a customer experience center. This move reflects Addison's emergence as a major enterprise technology hub along the Lower Dallas North Tollway, joining other tech leaders like Google, ServiceNow, and AWS.
Ipsos announced the appointment of Mitch Barns as Chairman and CEO of its Americas region, effective November 2, 2026. Barns, a veteran industry leader who previously served as Global CEO of Nielsen and CEO of The Opus Group, will oversee Ipsos operations in the US, Canada, and Latin America. He replaces Mary Ann Packo, who will depart at the end of November.
Archer Aviation is scheduled to report Q3 earnings on Nov. 9. While the planned acquisition of Boeing subsidiaries (Wisk Aero, Insitu, and SkyGrid) could significantly boost revenue by over $200 million annually, it will also cause shareholder dilution. The company is expected to report substantial losses ($170-200 million adjusted EBITDA loss), and with an uncertain FAA certification timeline, the author recommends waiting for more material progress before investing.
FORVIA, a global automotive supplier, has partnered with Raiqon GmbH to advance AI-powered engineering specification processes. The collaboration integrates Raiqon's multi-agent AI platform into FORVIA's existing IBM DOORS environment to automate technical requirement analysis, improve productivity, and accelerate product development while maintaining quality and compliance standards.
Apple launched its first touchscreen MacBook Pro at $2,899 (14-inch) and $3,399 (16-inch), charging a $400 premium over existing models with the same processor. Rather than raising prices across its entire Mac lineup amid rising memory chip costs, Apple is taking a selective approach by offering premium features to professional customers while maintaining cheaper alternatives. The strategy aims to protect profit margins, though the broader PC market is struggling with declining shipments.